Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson’s disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson’s disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial
Authors
Keywords
-
Journal
Chinese Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-24
DOI
10.1186/s13020-022-00572-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A non-parametric effect-size measure capturing changes in central tendency and data distribution shape
- (2020) Jörn Lötsch et al. PLoS One
- Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
- (2020) Tanya Simuni et al. JAMA Neurology
- Rasagiline combined with levodopa therapy versus levodopa monotherapy for patients with Parkinson’s disease: a systematic review
- (2019) De-Qi Jiang et al. NEUROLOGICAL SCIENCES
- Guidance on how to develop complex interventions to improve health and healthcare
- (2019) Alicia O'Cathain et al. BMJ Open
- Comparison of the Efficacy of Different Drugs on Non-Motor Symptoms of Parkinson’s Disease: a Network Meta-Analysis
- (2018) Bao-Dong Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Use and perceived effectiveness of complementary therapies in Parkinson's disease
- (2018) Sarah Donley et al. PARKINSONISM & RELATED DISORDERS
- Parkinson Disease
- (2018) Stephen G. Reich et al. MEDICAL CLINICS OF NORTH AMERICA
- Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials
- (2018) Chun-Shuo Shan et al. Frontiers in Aging Neuroscience
- Multi-dimensional analysis on Parkinson’s disease questionnaire-39 in Parkinson’s patients treated with Bushen Huoxue Granule: A multicenter, randomized, double-blinded and placebo controlled trial
- (2016) Min Li et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Pragmatic Trials
- (2016) Ian Ford et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PRECIS-2 tool: designing trials that are fit for purpose
- (2015) K. Loudon et al. BMJ-British Medical Journal
- The PRECIS-2 tool: designing trials that are fit for purpose
- (2015) K. Loudon et al. BMJ-British Medical Journal
- Effectiveness of Traditional Chinese Medicine as an Adjunct Therapy for Parkinson’s Disease: A Systematic Review and Meta-Analysis
- (2015) Guoxin Zhang et al. PLoS One
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death
- (2014) Yu-Ting Tseng et al. PHYTOMEDICINE
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Cognitive impairment and PD patients' capacity to consent to research
- (2013) J. Karlawish et al. NEUROLOGY
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search